SUGAR LAND, Texas, Aug. 28, 2017 -- Applied Optoelectronics, Inc. (Nasdaq:AAOI), a leading provider of fiber-optic access network products for the internet datacenter, cable broadband, fiber-to-the-home and telecom markets, today announced the development of 1310nm 50 Gbps Electro-absorption Modulated Lasers (EMLs) for 100G, 200G and 400G long reach transceivers.
The new 50 Gbps EML is based on AOI’s high yield, low cost and high reliability laser platform. It features high bandwidth, high output optical power, low driving voltage, and high extinction ratio. The new laser has demonstrated superior radio frequency performance at 25 Gbps NRZ with eye mask margin above 40% for the extinction ratio range of 4 dB to 9 dB. This makes it ideal for 100 Gbps long reach (10 km to 40 km) transceiver modules, such as 100GBASE-LR4 and 100GBASE-ER4, for datacenter interconnection (DCI). The high extinction ratio and high output optical power also makes it a good choice for future 100G EPON transceivers for FTTH applications. For 28 GBaud PAM-4 modulation, enabling 50 Gbps transmission, the dispersion eye closure quaternary (TEDCQ) value is typically smaller than 1.5 dB, making these lasers suitable for 200GBASE-LR4, 400GBASE-FR8, and 400GBASE-LR8 transceivers that meet the IEEE 802.3bs 200G / 400G Ethernet transceiver standards.
“High-speed EMLs are ideal for long transmission distance due to their small chirp and low chromatic dispersion in fiber. The new 50 Gbps EML product is an important complement to our existing 25G DMLs (Directly Modulated Lasers) that are extensively used in AOI’s market-leading 100 Gbps PSM4 and CWDM4 transceivers for intra-datacenter applications. These new lasers enable us to offer cost-effective long reach transceivers for the DCI market as well as enabling future 200G and 400G transceivers for DCI and other applications,” commented Dr. Jun Zheng, AOI’s VP and head of R&D.
About Applied Optoelectronics
Applied Optoelectronics Inc. (AOI) is a leading developer and manufacturer of advanced optical products, including components, modules and equipment. AOI's products are the building blocks for broadband fiber access networks around the world, where they are used in the internet datacenter, CATV broadband, FTTH and telecom markets. AOI supplies optical networking lasers, components and equipment to tier-1 customers in all four of these markets. In addition to its corporate headquarters, wafer fab and advanced engineering and production facilities in Sugar Land, TX, AOI has engineering and manufacturing facilities in Taipei, Taiwan and Ningbo, China. For additional information, visit www.ao-inc.com.
Media Inquiries: Willis Chen 281/295-1807 [email protected]


Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 



